Trials / Completed
CompletedNCT04948216
Management and Healthcare Utilization of Patients With Chronic Airway Disease During the COVID-19 Epidemic
Management and Healthcare Utilization of Patients With COPD and Asthma During the COVID-19 Epidemic in Beijing
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 153 (actual)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
During the COVID-19 epidemic, the medical treatment, disease status, and medication status of patients with chronic airway disease have not been studied. The purpose of this study is to investigate the management and healthcare utilization of patients with chronic airway disease and the influencing factors during the COVID-19 epidemic.
Detailed description
During the COVID-19 epidemic, the medical treatment, disease status, and medication status of patients with chronic airway disease have not been studied. The purpose of this study is to investigate the management and healthcare utilization of patients with chronic airway disease and the relevant factors during the COVID-19 epidemic. Using cross-sectional research methods, telephone interviews and questionnaire surveys were used to investigate the management and healthcare utilization of patients with chronic airway disease （COPD and asthma）during the COVID-19 epidemic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention |
Timeline
- Start date
- 2020-04-28
- Primary completion
- 2020-05-13
- Completion
- 2020-05-13
- First posted
- 2021-07-01
- Last updated
- 2021-07-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04948216. Inclusion in this directory is not an endorsement.